| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +19% |
| 3Y CAGR | +20% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +26% |
| 3Y CAGR | +152% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹3,754.70 -54.00 (1.42%) | 17,211.67 | 23.41 | 4.1 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,221.60 -37.20 (1.65%) | 16,883.72 | 24.9 | 5.01 | ||
Natco PharmaNATCOPHARM | ₹784.45 -16.40 (2.05%) | 15,397.22 | 13.45 | 1.47 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,079.50 +40.00 (0.66%) | 15,192.25 | 89.56 | 17.41 |